Last edition
News about "Nasdaq Global Select Market"
Sanofi Completes Acquisition of Dynavax, Expands Adult Vaccine Portfolio with HEPLISAV-B
Sanofi has finalised its acquisition of Dynavax, adding hepatitis B vaccine HEPLISAV-B and a shingles vaccine candidate to strengthen its global adult immunisation business.
NASDAQ Global Select Market | 12/02/2026 | By News Bureau | 191
Novo Nordisk Completes Acquisition of Akero Therapeutics
Novo Nordisk has finalised its acquisition of Akero Therapeutics, making Akero a wholly owned subsidiary. Following the transaction, Akero’s common stock will cease trading on the Nasdaq Global Select Market.
Nasdaq Global Select Market | 10/12/2025 | By Akanki | 223
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy